ArticleActa neuropathologica2023

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.

Justin Z Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.